Skip to main navigation HOME CONTACT ABOUT PRODUCT PIPELINE RESOURCES PARTNERING INVESTORS MEDIA CAREERS Corporate Governance Documents Audit Committee Compensation Committee Nominating and Corporate Governance Committee Code of Business Conduct and Related Open Door Policy Annual Declaration of Compliance for California Committee Composition Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below. Chairperson Member Financial Expert Chairman of the Board Audit Committee Compensation Committee Nominating and Corporate Governance Committee Stephen Biggar, M.D., Ph.D. Julian C. Baker Laura A. Brege Jim Daly Stephen R. Davis Edmund P. Harrigan, M.D. Daniel B. Soland Investor Relations INVESTORS STOCK INFORMATION NEWS RELEASES EVENTS & PRESENTATIONS SEC FILINGS CORPORATE GOVERNANCE FINANCIAL INFORMATION ANALYST COVERAGE ANNUAL REPORT AND PROXY INFORMATION REQUEST EMAIL ALERTS INVESTOR CONTACT Shareholder Tools Print Page RSS Feeds Share PRIVACY COOKIES PRIVACY SHIELD TERMS EMAIL © 2021 Acadia Pharmaceuticals Inc. Acadia and NUPLAZID are registered trademarks of Acadia Pharmaceuticals Inc. All rights reserved. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our Cookie Policy. ACCEPT